Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts

Journal of General Internal Medicine

Volumn 32, Issue 12, 2017, Pages 1315-1322

  Bowler, Russell P ^a,b   Hansel, Nadia N ^c   Jacobson, Sean ^b   Graham Barr, R ^d   Make, Barry J ^b   Han, Mei Lan K ^e,f   O’Neal, Wanda K ^g   Oelsner, Elizabeth C ^d   Casaburi, Richard ^h   Barjaktarevic, Igor ⁱ   Cooper, Chris ⁱ   Foreman, Marilyn ^j   Wise, Robert A ^c   DeMeo, Dawn L ^k   Silverman, Edwin K ^k   Bailey, William ^l   Harrington, Kathleen F ^l   Woodruff, Prescott G ^m   Drummond, M Bradley ^g  

^a UNIVERSITY OF COLORADO   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h HARBOR UCLA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j MOREHOUSE SCHOOL OF MEDICINE   (United States)

^k HARVARD MEDICAL SCHOOL   (United States)

^l University of Alabama at Birmingham   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

COPD; electronic cigarette; lung function; tobacco

Indexed keywords

NICOTINE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; RACE DIFFERENCE; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; UNITED STATES; VAPING; AGED; BRONCHITIS; CIGARETTE SMOKING; CLINICAL TRIAL; ELECTRONIC CIGARETTE; HARM REDUCTION; LONGITUDINAL STUDY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; UTILIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHITIS; CIGARETTE SMOKING; COHORT STUDIES; DISEASE PROGRESSION; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HARM REDUCTION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; TOBACCO USE DISORDER; UNITED STATES; VAPING;

EID: 85028958769     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-017-4150-7     Document Type: Article

References (28)

1. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014; 23(2):133–9.
2. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013; 8(6):e66317.
3. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013; 382 (9905):1629–37.
4. Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: An eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res. Public Health. 2014; 11 (11):11220–48.
5. Tseng TY, Ostroff JS, Campo A, Gerard M, Kirchner T, Rotrosen J, et al. A Randomized Trial Comparing the Effect of Nicotine Versus Placebo Electronic Cigarettes on Smoking Reduction Among Young Adult Smokers. Nicotine Tob Res. 2016; 18 (10):1937–43.
6. Ghosh S, Drummond MB. Electronic cigarettes as smoking cessation tool: are we there? Curr Opin Pulm Med. 2016.
7. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016; 4(2):116–28.
8. E-cigarette use triples among middle and high school students in just one year. CDC Newsroom: Centers for Disease Control and Prevention; 2015.
9. Farsalinos KE, Poulas K, Voudris V, Le Houezec J. Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction. 2016.
10. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010; 7(1):32–43.
11. Couper D, LaVange LM, Han M, Barr RG, Bleecker E, Hoffman EA, et al. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax. 2014; 69(5):491–4.
12. Fabbri LM, Hurd SS, Committee GS. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J. 2003; 22(1):1–2.
13. Wan ES, Castaldi PJ, Cho MH, Hokanson JE, Regan EA, Make BJ, et al. Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res. 2014; 15:89.
14. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992; 145(6):1321–7.
15. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988; 93(3):580–6.
16. Kim V, Han MK, Vance GB, Make BJ, Newell JD, Hokanson JE, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest. 2011; 140(3):626–33.
17. Suh-Lailam BB, Haglock-Adler CJ, Carlisle HJ, Ohman T, McMillin GA. Reference interval determination for anabasine: a biomarker of active tobacco use. J Anal Toxicol. 2014; 38(7):416–20.
18. Bowler RP, Kim V, Regan E, Williams AAA, Santorico SA, Make BJ, et al. Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest. 2014; 146(4):941–50.
19. Keene JD, Jacobson S, Kechris K, Kinney GL, Foreman MG, Doerschuk CM, et al. Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. Am J Respir Crit Care Med. 2016.
20. Schoenborn CA, Gindi RM. Electronic Cigarette Use Among Adults: United States, 2014. NCHS Data Brief. 2015 (217):1–8.
21. QuickStats: Cigarette Smoking Status Among Current Adult E-cigarette Users, by Age Group—National Health Interview Survey, United States, 2015. MMWR Morb Mortal Wkly Rep 2016; 2016.
22. Nitzkin JL. The case in favor of E-cigarettes for tobacco harm reduction. Int J Environ Res Public Health. 2014; 11(6):6459–71.
23. Hiemstra PS, Bals R. Basic science of electronic cigarettes: assessment in cell culture and in vivo models. Respir Res. 2016; 17(1):127.
24. Gardiner PS. The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res. 2004; 6 Suppl 1:S55–65.
25. Soule EK, Lopez AA, Guy MC, Cobb CO. Reasons for using flavored liquids among electronic cigarette users: A concept mapping study. Drug Alcohol Depend. 2016; 166:168–76.
26. Kosmider L, Sobczak A, Prokopowicz A, Kurek J, Zaciera M, Knysak J, et al. Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax. 2016; 71(4):376–7.
27. Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes EJ, Enright PL. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med. 2002; 347(5):330–8.
28. Etter JF, Zather E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction. 2013; 108(9):1671–9.